drugset / Trial / NCT06758752
A Herbal Compound for Eczema
Phase 2
Active not recruiting
110 enrolled
Fasa University of Medical Sciences
Herbmedx Co · collabZarrin Avaye Kowsar Salamat (ZAX company) · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
The goal of this interventional clinical trial study is to compare ZAX.1400.EC.02 and placebo in Eczema patients. The main question it aims to answer is: • Can treatment with ZAX.1400.EC.02 for 3 weeks improve clinical signs of skin in Eczema patients? Participants will be divided into two groups. One group will use ZAX.1400.EC.02 topically twice daily for 3 weeks and the other group will use placebo topically twice daily for 3 weeks. Researchers will compare treatment and placebo groups to see if there is any improvement in the clinical signs of skin caused by Eczema after treatment with ZAX.1400.EC.02 for 3 weeks.
Timeline
- Start
- 2023-10-01
- Primary completion
- 2026-12-30
- Completion
- 2026-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ZAX.1400.EC.02 | Unknown | — | Topical |